Prevention of Serious Adverse Events Following Angiography
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 5177 participants.
Also called NCT01467466
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 5,177 participants
- Registry
-
NCT01467466
-
- Other papers using this trial's data
- Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Australia, Malaysia, New Zealand
- Registry status
- Completed
Technical summary
Registry record NCT01467466. Randomized; double masking; primary purpose prevention. Start 2013-10-07 (actual); primary completion 2017-09-29 (actual). Results posted on 2018-11-09.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Prevention of Serious Adverse Events Following Angiography
- Acronym
- PRESERVE
- Condition
- Acute Renal Failure
- Condition
- Kidney Disease
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- IV isotonic saline
- Intervention (Drug)
- IV isotonic bicarbonate
- Intervention (Drug)
- N-acetylcysteine
- Intervention (Drug)
- Placebo
- Lead sponsor
- VA Office of Research and Development
- Collaborator
- The George Institute
Record details
- Record id
cardio:ct-nct01467466- Content hash
e611b5e6e612ed54a5e4331131f8983dc5f3ff2d80e6efdce0070e5eaefb1e39